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The calcium channel blocking agent, diltiazem, improves
ischemia-induced conduction delays in the canine heart.
H is not known, however, if the improvement of myo-
cardial blood flow caused by diltiazem participates in
this response. Accordingly, ischemia-induced conduc-
tion delay was measured during brief coronary artery
occlusion before and after administration of diltlazem
in nine anesthetized pigs with fixed heart rate. Acute
coronary occlusion prolonged subendocardial (mean ±
standard error of the mean, 39.9 ± 3.9 ms) and subep-
icardial (41.6 ± 4.1 ms) conduction times (time to peak
of the bipolar electrogram in each region) by 51 ± 4
and 58 ± 5%, respectively. Regional myocardial blood
flow at the ischemic electrode sites was 0.006 ± 0.002
The specific mechanisms underlying ventricular ectopic beats
occurring during acute myocardial ischemia are unknown
(I). Circus movement established by ischemia-induced con-
duction disturbances seems to play a major role in the de-
velopment of ventricular tachycardia or fibrillation (2,3).
Several studies (5-8) have demonstrated a quantitative re-
lation between the severity of conduction delay and the
development of ventricular arrhythmias. Diltiazem, a cal-
cium channel blocking agent , has been reported to reduce
the conduct ion delay that occurs during acute coronary oc-
clusion in dogs (9-11). Other calcium channel blocking
agents , including verapamil (9, 10,12, 13) and nifedipine
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ml/min per g and was unaffected by diltiazem.
Intravenous diltiazem pretreatment (0.01, 0.1, 0.3
and 1.0 mg/kg) 5 minutes before coronary occlusion sig-
nificantly reduced the ischemia-induced conduction de-
lay in both subendocardial and subepicardial regions
during coronary occlusion. The pigs in which ventricular
fibrillation occurred within 10 minutes showed a signif-
icantly longer conduction delay than that observed in
pigs in which ventricular fibrillation occurred later (>
10 minutes).
Thus, the data suggest that the reduction of ischemia-
induced conduction delay produced by diltiazem is in-
dependent of blood flow changes and, therefore, that
diltiazem may have a beneficial antiarrhythmic action.
(10,14) , have similar effects. However, in canine hearts
with a variable but inherently well developed coronary col-
lateral circulation (15,16), it is possible that the favorable
effects of diltiazem and other calcium channel blocking
agents on the ischemia-induced conduction delay may result
from improved myocardial blood flow because these drugs
are potent coronary vasodilators (17-19).
In contrast to the coronary vascular bed of the canine
heart , it has been reported that few collateral channels exist
in the porcine coronary circulation (15,16) . Accordingly,
this study was undertaken to determine if diltiazem can
decrease the conduction delay in ischemic myocardium in-
dependent of changes in regional myocardial blood flow in
the ischemic regions of the porcine heart.
Methods
Animal preparation. Nine young domestic pigs weigh-
ing 18 to 30 kg were anesthetized with ketamine (5 mg/kg
body weight intramuscularly) and alpha-chloralose (75 to
100 mg/kg, intravenously). Administration of alpha-chlor-
alose was repeated, as necessary, to maintain anesthesia .
After the pig was intubated and artificially ventilated with
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room air, the heart was exposed by way of a midline ster-
notomy and suspended in a pericardial cradle. A Tygon
catheter was inserted and secured in the left atrium for the
injection of radiolabeled microspheres. The right femoral
artery was cannulated to monitor systolic blood pressure and
collect a reference timed arterial blood sample during rni-
crosphere injection to quantitate regional myocardial blood
flow. A standard lead II electrocardiogram was monitored
continuously during the experiments
Electrographic recording and analysis. The heart was
paced at a basic cycle length of 500 ms with a bipolar surface
electrode placed at the right ventricular outflow area. Stimuli
were retangular pulses of 2 ms duration at twice the diastolic
threshold voltage (Grass S48 stimulator).
Two 22 gauge decapolar plunge electrodes were placed
at least I em apart in the potentially ischemic core zone of
the anterior left ventricular wall. The distance between re-
cording sites on each electrode was I mm. Two adjacent
recording sites located close to the subepicardium and sub-
endocardium were selected on each electrode to record bi-
polar electrograms. A bipolar plunge electrode was inserted
into the subepicardium of nonischemic zone. The electrical
signals were amplified, filtered between 40 and 500 Hz
(MECA EA-8), displayed on a storage oscilloscope (Tek-
tronix 5115) and photographed with a Polaroid camera (Tek-
tronix C59). Time to onset, time to peak, duration and
amplitude of each electrogram were measured.
Regional myocardial blood How determination. Re-
gional myocardial blood flow and its transmural distribution
were determined by differential spectrometry of tissue sam-
ples after injections of 2 million 15 fLm radioactive mi-
crospheres, labeled with cerium-141, chromium-51, niobi-
um-95 or ruthenium-I 03. The microspheres were dispersed
by sonification before use and injected into the left atrium
over a period of 15 seconds. A simultaneous, timed blood
collection was made through an arterial catheter over a 2
minute period beginning 15 seconds before the isotope in-
jection using a Harvard infusion/withdrawal pump (model
941).
At the end of the experiments, a transmural tissue block
was removed from the normal and ischemic zones in which
each electrode was inserted, divided into three portions (ep-
icardial, midmyocardial and endocardial) and weighed. Each
portion and reference blood sample were counted using a
Packard autogamma scintillation counter (model A5980).
Regional myocardial blood flow (Qm, m l/min per g tissue)
was calculated by the reference sample method using the
following equation: Qm = (Qr X Crn/Cr) /wt, where Qr
is the rate of withdrawal (m I/min) of the reference blood
flow sample, Cm is the activity (counts) of the myocardial
tissue sample, Cr is the activity (counts) of the reference
blood sample and wt is the tissue sample wet weight (20).
Experimental protocol. After heparinization (250 units/
kg), the left anterior descending coronary artery was gently
occluded at its midportion by a rubber occluder (Vesse-
loops). In all pigs, coronary artery occlusion (:53 minutes)
was produced three times at intervals of 45 minutes. Such
a short-term occlusion was selected because preliminary
experiments revealed that longer periods of myocardial
ischemia invariably resulted in ventricular fibrillation and
caused irreversible changes in the bipolar electrograms, None
of these three brief occlusions gave rise to ventricular fi-
brillation in the pigs studied. The first labeled microsphere
batch was injected to measure baseline regional myocardial
blood flow. A control occlusion was then performed to
determine the electrophysiologic responses that occurred
during ischemia before drug treatment. A second, differ-
ently labeled microsphere batch was injected at 45 seconds
after starting this occlusion. Two additional occlusions were
produced at 45 minute intervals 5 minutes after pretreatment
with a "low" (10 or 100 fLg/kg) and "high" (300 or 1,000
fLg/kg) dose of diltiazem. Differently labeled microspheres
were given during these left anterior descending artery oc-
clusions. One hour was allowed to elapse after the last
occlusion and a final permanent occlusion was performed
to determine the relation between severity of bipolar elec-
trographic changes and survival time.
Statistical analysis. All data are presented as mean ±
standard error of the mean. Data were converted to percent
change in some illustrations to allow a uniform results com-
parison. All statistical analyses were performed on actual
raw data as well as on percent changes. Values obtained
from the same pig were compared using paired Student' s t
tests. Values obtained in different pigs were compared using
analysis of variance with Duncan's multiple range test ap-
plied. Significance was established when the probability
value was less than 0.05 .
Results
Regional bipolar electrograms and myocardial blood
flow during brief coronary occlusion. Brief coronary ar-
tery occlusion produced marked changes in the bipolar elec-
trograms in the ischemic myocardial zone without any changes
in the nonischemic zone (Fig. I). Before coronary occlu-
sion, the time to onset, time to peak, and duration of the
bipolar electrograms were 33.5 ± 3.7 , 39.9 ± 3.9 and
15.9 ± 1.1 ms in subendocardium and 35.4 ± 3.8 ,41 .6
± 4.1 and 16.2 ± 1.4 ms in subepicardium, respectively
(nine pigs, 18 electrode sites). The time to onset or time to
peak in ischemic subendocardium and subepicardium began
to decrease shortly after coronary occlusion. At I minute
after occlusion, the time to peak was slightly but signifi-
cantly shortened by 2.8 ± 1.0 and 2.7 ± 1.2 % in ischemic
subendocardium and subepicardium, respectively. This ac-
celerated conduction was followed by progressive conduc-
tion delay in the ischemic zone.
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± 2.0 ms and amplitude decreased by 48 .6 ± 4 .2% in
ischemic subendocardium. In the subepicardium, duration
increased by 49.4 ± 13.1 % to 24.9 ± 3.2 ms and amplitude
decreased by 49.0 ± 5.7% during ischemia. Although a
greater increase in the time to onset and the time to peak
occurred in the subepicardium and a larger change in du-
ration occurred in subendocardial regions , these alterations
were not significantly different.
Regional myocardial blood flow at the electrode sites
within the ischemic zone was markedly decreased during
coronary artery occlusion (Table I). Systemic pressure de-
creased from 95 ± 3/69 ± 3 (systolic/diastolic) to 75 ±
3/53 ± 3 mm Hg at the beginning of right ventricular
pacing. Complete occlusion of the left anterior descending
coronary artery reduced the blood flow at both subendo-
cardial and subepicardial sites in the ischemic zone well
below the level of resolution by the microsphere method
« 0 .05 mllmin per g) and was not significantly different
from zero blood flow.
Effects of diltiazem. Pretreatment with diltiazem (10 to
1,000 j.Lg/kg) produced a dose-dependent attenuation of the
bipolar electrographic changes induced by coronary occlu-
sion. A representative example is shown in Figure I. In this
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Figure 2. Bipolar electrographic changes induced by acute coro-
nary occlusion in nine porcine hearts. Column with vertical bar
expresses mean ± standard error of the mean value of percent
changes in each variable . **p < 0.01 , ***P < 0.001. Endo =
endocardial bipolar electrogram ; Epi = epicardial electrogram .
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The bipolar electrographic changes in the ischemic sub-
endocardium and subepicardium at the end of the control
coronary occlusion are summarized in Figure 2. The time
to onset was increased significantly by 26.4 ± 7.9% to 39.7
± 3.7 ms and by 37 .7 ± 6.5 % to 46.4 ± 4 .3 ms in
subendocardium and subepicardium, respectively. At the
end of the occlusion period, the time to peak was increased
by 35 .8 ± 6.6% to 51.3 ± 4.3 ms and by 45.0 ± 6.1%
to 57 .8 ± 5.1 ms in subendocardium and subepicardium,
respectively. Duration increased by 75 .8 ± 17.2% to 26.5
Figure 1. Effect of diltiazem on ischemia-induced conduction
delay in the porcine heart. A, Control coronary occlusion (no
drug) . B, Coronary occlusion after pretreatment with 10 ILg/kg of
diltiazem and C, After 1,000 ILg/kg of diltiazem. D, Recovery
occlusion performed I hour after last administration of diltiazem.
Left and right panels indicate electrograms recorded before and
2 minutes after occlusion, respectively . 1 = electrocardiographic
lead II, 2 = subepicardial bipolar electrograms in normal zone,
3 = subendocardial bipolar electrogram in ischemic zone I, 4 =
epicardial electrogram in ischemic zone I, 5 = endocardial elec-
trogram in ischemic zone 2, 6 = epicardial electrogram in ischemic
zone 2, S = stimulus artifact. Time scale of 50 ms is shown at
the bottom.
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Table l. Regional Myocardial Blood Flow (RMBF) in ml/g per mm Before and During Occlusion Before and After Adminstration
of Diltiazem
Control Control
Dilnazem (JLglkg) and Occlusion
(Preocclusion) (Occlusion) 10 100 300 1.000
Nomschermc Zone
Endo 0.54 :!: 0.06 0 5 1 :!: 0 08 0.50 :!: 008 0 53 :!: a as 0.53 :!: 0 . 12 0 .74 :!: 0 21
Epi 0.67 :!: 0.08 0.62 :!: 0.08 0.60 :!: 0 09 0 .74 :!: 0 II 0.69 :!: 0.20 090:!:0. 18
n 8 8 4 5 3 4
Ischemic Zone
Endo 0 .5 1 :!: 0.0 4 < 0 05* < 0.05 < aas < 0 .05 < a as
Epi 0 .62 ± a as < 0.05* < 0.05 < 0.05 < a as < 0.05
n 16 16 8 10 6 8
*Probabihty (p) < 0.05 from control (preocclusron) values. Values are expressed as mean ± standard error of the mean . Regional myocardial blood
flow values dunng occlusion with diltiazem pretreatment were compared with those during control occlusion None of values 10 the nonischerru c and
Ischemic zones was significantly different from those during control occlusion . Endo and Epi = endocardium and epicardium. respectively: n = number
of tissue samples.
experiment, control coronary occlusion (2 minutes) produced
a marked change of the bipolar electrograms in both the
ischem ic subendoc ardial and subepicardial regions (Fig. lA ,
right panel ). After a bolus intrave nous injection of 10 I-Lg/
kg of diltiazem , the bipol ar electrog raphic changes produ ced
by 2 minutes of occlusion (Fig. IB, right panel) were less
than those occurring durin g the control occlusion. Pretreat-
ment with 1,000 I-Lg/kg of dilt iazem prevented most of the
ischemia-induced electrographic changes (Fig . IC) . One
hour after administration of 1,000 I-Lg/kg of dilti azem , the
coro nary artery was permanentl y occl uded (Fig. ID). The
bipolar elec trographic changes returned toward the control
occl usio n response and ventricular fibrillat ion occurred at
36 minutes after the final permanent occlusion.
The effects ofdiltiazem on the time to peak prolongation
are summarized in Figure 3 . The increase in this interval
produ ced by control coronary occlusion was established as
the 100% response again st which subsequent responses dur-
ing occlusion were measured. In control occ lusions, time
to peak prolongation increase d from 39.9 ± 3.9 to 51 .3 ±
4 .3 ms in subendocardial regions and from 4 1.6 ± 4 . 1 to
57.8 ± 5. 1 ms in subepicardial regions. Intravenous admin-
istration of 10 I-Lg/kg of dilti azem . 5 minutes before coron ary
occl usion, decreased the time to peak prolongation in the
subepicardial region to 54 ± 7% (p < 0.05) of that observed
during the previous cont rol occlusion. The time to peak
prolongation was not significantly decreased in subendo-
card ial regions. Diltiazem doses greater than 100 I-Lg/kg
significantly reduc ed both subendocardial and subepicardial
conduction delay; for example . after a dose of 1,000 I-Lg/kg
diltiazem , the time to peak prolongat ion durin g ischemia
was only 16 ± 5% of that recorded in the subendocardium
and 9 ± 4% of that recorded in the subepicardium dunng
the control occlusion. One hour after the last diltiazem treat-
ment, conduction delay during occl usion had returned to-
ward control.
Pretreatment with diltiazem did not significantly affect
regional myocardial blood flow in the nonischemic and isch-
emic zones at the time coronary occlusion was initiated
(Table I ). Blood flow in the nonischemic zone , however .
tended to increase after the high doses of dilti azem . The
mean value of regional myocardi al blood flow in ischemic
zones was always less than 0.05 mllmin per g, indicating
that these zones were severe ly flow-deprived regardless of
the dilt iazem dose adm inistered .
Relation between sever ity of the ischemia-induced
conduction delay and survival time during permanent
occlusion. Eight pigs , with permanent coronary occlusion
carried out 60 minut es after the last diltiazem dose was
given, died of ventri cular fibrillation in less than 10 minutes
(early group, n = 4) or after more than 10 minute s (late
group , n = 3) (Table 2). The mean time of ventricular
fibrillation in the early group was 5.8 minutes, whereas in
the late ventricular fibrillat ion group, three pigs died of
ventri cular fibrillation with a mean group survival time of
29 .5 minut es . One pig did not develop ventricular fibril-
lation and was sacrificed 45 minutes after occlusion . The
early ventricular fibrillation group showed significantly greater
increase of the time to peak pro longation in both suben-
docardia l (~ = 8.5 ± 2. 1 ms) and subepicardial (~ = 8.7
± 2.4 ms) bipolar electrograms at 2 minute s than did the
late ventricular fibrillat ion gro up where time to peak pro-
longation was increased 1.4 ± 0.8 ms in subendocardial
regions and 1.8 ± 1.2 ms in subepicardial region s. How-
ever, as shown in Figure 4 , no clear relation between changes
of the time to peak and survival times was observed in these
few experiments.
Discussion
Rapid and marked bipolar electrographic changes in
ischemic pig hearts. Brief coronary occlusion in pig heart s
induced similar changes in the electrograms to those de-
scribed for the ischemic dog heart preparation (2,5-14).
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Figure 3. Effect of diltiazern on conduction delay
in ischemic subendocardium (Endo) and subepi-
cardium (Epi) in nine porcine hearts. The doses of
diItiazem are plotted on the abscissa and percent
valuesof time to peak prolongationobserved during
control coronary occlusion are expressed on the or-
dinate. Recovery occlusion was performed I hour
after the last dose of diItiazem. * p < 0.05 , **P
< 0.01 and ***p < 0.001 from time to peak
changes produced by control (no drug) occlusion.
10 100 300 1000 Recovery
Diltiazem (ug/kg)
The conduction delay (prolongation of time to onset and
time to peak delay), increase of electrogram duration and
loss of electrogram amplitude appeared immediately after
transient accelerated conduction. In pigs, however, the elec-
trographic changes developed more rapidly than those ob-
served in dogs (2,9,12). The short-term (2 to 3 minutes)
occlusion in the pigs anesthetized with alpha-chloralose
produced these electrophysiologic changes despite reports
that ischemia-induced conduction delay is less with alpha-
chloralose than with pentobarbital anesthesia (21). Ruffy et
at. (22) reported that the mean values of the time to onset
and the time to peak conduction delay were prolonged not
more than 10% in canine ischemic subepicardial regions
where myocardial blood flow was decreased to 0 to 25% of
control flow values. They also showed that the magnitude
of conduction delay at subendocardial sites was significantly
less than that observed at subepicardial sites when a com-
parable reduction in flow was observed. In our pig exper-
iments, however, the time to peak delay in subendocardium
and subepicardium was prolonged 36 and 45%, respec-
tively , and no significant differences were found between
the magnitude of conduction delay in subendocardial and
subepicardial regions.
One possible explanation for the discrepancy between
our data and those of Ruffy et at. (22) is that coronary
occlusion in pigs produces a more severe and homogeneous
cardiac ischemia with regional myocardial flow decreasing
less than 0.01 mllmin per g. Therefore, the greater reduction
in flow observed in pig hearts probably accounts for these
differences. In this context, extracellular potassium accu-
mulation, one of the major factors responsible for the elec-
trophysiologic changes during myocardial ischemia (23),
has been shown to be greater in the subendocardium than
in the subepicardium of ischemic pig hearts (24). A second
possibility is that pig myocardial cells are more sensitive
electrophysiologically to the ischemic environment , that is,
Table 2. Percent Change of Time to Peak Conduction Delay in Ischemic Zone at 2 Minutes During Permanent Occlusion in Pigs
With Early « 10 min) and Late (> 10 min) VentricularFibrillation (VF)
Percent Change of Time to Peak Delay at 2 Minutes
Pigs
Early VF « 10 min)
(4 pigs . 8 electrode sites)
Late VF (>10 min)
(4 pigs, 8 electrode sites)
Subendocardium
30.7 ± 8.1
4.5 ± 2.0
p < 0.05
30.2 ± 8.6
4.8 ± 2.2
Subepicardium
p < 0.05
The mean survival times of pigs with early and late ventricular fibnllation were 5.8 minutes (n = 4) and 29.5 minutes (n = 3), respectively. One
of the four pigs in the late ventricular fibrillation group was sacrificed at the end of the 45 minute occlusion observation period. See text for actual values
in time to peak conduction delay for the two regions in these groups.
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hypoxic, hyperkalemic and acidic conditions, than are dog
heart cells.
Flow-independent improvement of ischemia-induced
conduction delay with diltiazem. Diltiazem produced a
dose-dependent protective effect against the ischemia-in-
duced conduction delay. Pretreatment with 10 j.Lg/kg of
diltiazem, which is less than the reported clinically thera-
peutic dose (25,26), produced significant protection against
conduction delay only in the subepicardial region. The ex-
tent of improvement in conduction delay observed after 100
to 300 j.Lg/kg is comparable with that observed in canine
ischemic hearts (9- 11)'-
In contrast with the marked improvementof the ischemia-
inducedconduction delay, diltiazemhad no detectableeffect
on regional myocardial blood flow at the electrode site in
the ischemic zone. This is not surprising because our pre-
vious studies (20) and those of others (27) have demon-
strated that diltiazem does not increase blood flow to se-
verely ischemic zones of either porcine or canine hearts. It
is possible, but highly unlikely, that improvement of re-
gional perfusion below the level of detection by the mi-
crosphere method may have contributed to the salutary ac-
tion observed. This possibility is made less likely by
observations that nifedipine, a calcium blocking agent of
Figure 4. Relation between changes of time to peak conduction
delay and survival time. Changes of time to peak conduction delay
(mean values) of two electrode sites observed in subendocardium
(ll) and subepicardium (0 ) at 2 minutes during terminal coronary
occlusionare plottedon the abscissa. Thesurvival timesare plotted
on theordinate. One of the nine pigs wassacrifi ced at45 minutes.
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more potent coronary vasodilating action, produced an in-
consistent effect on ischemic-induced conduction delay
(12 ,28). It has also been reported that another calcium chan-
nel blocking agent, verapamil (29), creatine phosphate (30,31)
and prostacyclin (32) can each exert a direct salutary effect
on electrophysiologic abnormalities during myocardial is-
chemia. Direct action on an ionic channel under hypoxic or
ischemic conditions may be contributory (33).
Failure to detect significant increases in blood flow to
the normal zones after the administration of diltiazem prob-
ably results from the delay between the drug administration
and flow determination (about 6 minutes) in the present
series of experiments. As Bache and Dymek (34) and we
( 19) have shown previously, the coronary blood flow re-
sponse to bolus intravenous diltiazem injection over the dose
range used is complete in less than 5 minutes. The mech-
anisms involved in the diltiazem-induced protection are clearly
complex and membrane-related and may not be shared by
all of the calcium antagonists (35,36) .
Implications. Pretreatment with diltiazem can retard the
conduction delay observed in ischemic pig myocardium in-
dependent of myocardial perfusion. The observedbeneficial
effect of diltiazem on conduction disturbances may, in part,
explain the antifibrillatory effect of the drug during acute
coronary occlusion in both dogs (37,3 8) and pigs (39).
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